Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer

Drug repurposing provides a cost-effective approach to address the need for lung cancer prevention and therapeutics. We aimed to identify actionable druggable targets using Mendelian randomization (MR).